Boehringer Ingelheim Praxbind
No reviews yet
Description: Descriptions Praxbind® is a specific reversal agent for dabigatran and is indicated in adult patients treated with Pradaxa® (dabigatran etexilate) when rapid reversal of its anticoaculant effects is required: for emergency surgery/urgent procedures; in life-threatening or uncontrolled bleeding.
Boehringer Ingelheim Pradaxa
No reviews yet
Description: Descriptions Prevention of strokes and blood clots in patients with abnormal heart rhythm (atrial fibrillation). Primary prevention of venous thrombo-embolic events (VTE) in adults after elective total hip or knee replacement surgery. Treatment of deep vein thrombosis (DVT) and pulmonary…
Boehringer Ingelheim Metalyse
No reviews yet
Description: Descriptions Fibrinolytic treatment of acute myocardial infarction.
Boehringer Ingelheim Lendormin
No reviews yet
Description: Descriptions Short-term treatment of disorders of initiating and maintaining sleep. Insomnia requiring pharmacological intervention.
Boehringer Ingelheim Jentadueto
No reviews yet
Description: Descriptions Treatment of type 2 diabetes mellitus to improve glycaemic control in adults when treatment with metformin does not lead to sufficient control or when patients are treated with Trajenta® (linagliptin) and metformin.
Boehringer Ingelheim Jardiance
No reviews yet
Description: Descriptions Treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control and to reduce the risk of cardiovascular death in patients with established cardiovascular disease.
Boehringer Ingelheim Glyxambi
No reviews yet
Description: Descriptions Treatment of type 2 diabetes mellitus to improve glycaemic control in adults when treatment with both empagliflozin and linagliptin is appropriate (US).
Boehringer Ingelheim Giotrif
No reviews yet
Description: Descriptions For the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have activating epidermal growth factor receptor (EGFR) mutations. For the treatment of patients with locally advanced or metastatic NSCLC of squamous histology progressing on or…